| Product NDC: | 0187-5115 |
| Proprietary Name: | Ertaczo |
| Non Proprietary Name: | Sertaconazole Nitrate |
| Active Ingredient(s): | 20 mg/g & nbsp; Sertaconazole Nitrate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0187-5115 |
| Labeler Name: | Valeant Pharmaceutials North America LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021385 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130101 |
| Package NDC: | 0187-5115-60 |
| Package Description: | 1 TUBE in 1 CARTON (0187-5115-60) > 60 g in 1 TUBE |
| NDC Code | 0187-5115-60 |
| Proprietary Name | Ertaczo |
| Package Description | 1 TUBE in 1 CARTON (0187-5115-60) > 60 g in 1 TUBE |
| Product NDC | 0187-5115 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sertaconazole Nitrate |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20130101 |
| Marketing Category Name | NDA |
| Labeler Name | Valeant Pharmaceutials North America LLC |
| Substance Name | SERTACONAZOLE NITRATE |
| Strength Number | 20 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |